Načítá se...
Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease
Serum vedolizumab concentrations are associated with clinical response although, it is unknown if vedolizumab concentrations predict response to dose escalation. The aim of this study was to identify if vedolizumab trough concentrations predicted the response to vedolizumab dose escalation. We asses...
Uloženo v:
| Vydáno v: | J Clin Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7601452/ https://ncbi.nlm.nih.gov/pubmed/32998473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9103142 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|